U0126 prevents ERK pathway phosphorylation and interleukin-1β mRNA production after cerebral ischemia

Chinese Medical Sciences Journal

Volumn 19, Issue 4, 2004, Pages 270-275

  Wang, Zhi Qiu ^a   Chen, Xian Cheng ^a   Yang, Guo Yuan ^b   Zhou, Liang Fu ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cerebral ischemia; Interleukin 1; Mitogen activated protein kinases

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; INTERNAL JUGULAR VEIN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; RIBONUCLEASE PROTECTION ASSAY; SUTURE; WESTERN BLOTTING;

ANIMALS; BUTADIENES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; ETS-DOMAIN PROTEIN ELK-1; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 12344257195     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wang ZQ, Chen XC, Zhou LF, et al. Effects of extracellular signal-regulated (ERK) on focal cerebral ischemia. Chin Med J (Engl) 2003;116:1497-503.
2. Wang ZQ, Wu DC, Huang FP, et al. Inhibition of MEK/ERK1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 2004;996:55-66.
3. Fukunaga K, Miyamoto E. Role of MAP kinase in neurons. Mol Neurobiol 1998;16:79-95.
4. Bendinelli P, Piccoletti R, Maroni P, et al. The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett 1996;398:193-7.
5. Song L, Shen B, Li Y. Association and contribution of ERK to IL-6-induced activation of signal transducer and activator of transcription in a human myeloma cell line. Chin Med J 2001;114:954-7.
6. Hu BR, Liu CL, Park DJ. Alteration of MAP kinase pathways after transient forebrain ischemia. J Cereb Blood Flow Metab 2000;20:1089-95.
7. Alessandrini A, Namura S, Moskowitz MA, et al. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. PNAS 1999;96:12866-9.
8. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 1999;100:203-15.
9. Wang ZQ, Chen XC, Yang GY, et al. Changes of ICAM-1, Mac-1 and MPO activity in focal cerebral ischemic mice. Fudan Univ J Med Sci 2003;30:304-7.
10. Yang GY, Mao Y, Zhou LF, et al. Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce bover-expression of interleukin-1 receptor antagonist. Mol Brain Res 1999;65:143-50.
11. Yang GY, Mao Y, Zhou LF, et al. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist. Mol Brain Res 1999;72: 129-37.
12. Yang GY, Schielke GP, Gong C, et al. Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1β converting enzyme deficient mice. J Cereb Blood Flow Metab 1999;19:1109-17.
13. Rezzonico R, Chicheportiche R, Imbert V, et al. Engagement of CD11b and CD11cβ2 integrin by antibodies or soluble CD23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 2000;95:3868-77.
14. Jaffee BD, Manos EJ, Collins RJ, et al. Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. Biochem Biophys Res Commun 2000;268:647-51.